Global Autologous CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

Page: 75

Published Date: 06 Sep 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

The global Autologous CAR-T Cell Therapy market size is expected to reach $ 14750 million by 2030, rising at a market growth of 21.6% CAGR during the forecast period (2024-2030).

Cell immunotherapy techniques, represented by chimeric antigen receptor T-cell immunotherapy (CAR-T therapy), express CAR fusion proteins on the surface of T cells through genetic engineering technology. The CAR extracellular antigen recognition region (one of the components of CAR cells, responsible for recognizing tumor cell surface antigens) can specifically recognize tumor antigens and transmit signals into cells to activate T cells, achieving proliferation and targeted killing of tumor cells. CAR-T therapy has shown breakthrough efficacy and enormous potential for development and market prospects for cancer patients who are unable to cope with traditional treatments. CAR-T cells are divided into autologous and allogeneic CAR-T cells. At present, CAR-T therapy mainly uses autologous CAR-T cells.

In recent years, the progress of autologous CAR-T cell therapy in hematological tumors has inspired scientists to extend this technology to the treatment of solid tumors. However, the current progress in the treatment of solid tumors is relatively slow. But in the future, with the discovery of more targets and the development of clinical trials, solid tumors are expected to become the main treatment area for CAR-T. At present, JW (Cayman) Therapeutics is laying out more innovative products to officially enter the field of cell therapy for solid tumors.

This report studies the global Autologous CAR-T Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Autologous CAR-T Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autologous CAR-T Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Autologous CAR-T Cell Therapy total market, 2019-2030, (USD Million)
Global Autologous CAR-T Cell Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Autologous CAR-T Cell Therapy total market, key domestic companies, and share, (USD Million)
Global Autologous CAR-T Cell Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global Autologous CAR-T Cell Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Autologous CAR-T Cell Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Autologous CAR-T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JW (Cayman) Therapeutics, Gilead (Kite Pharma), Bristol Myers Squibb, Novartis, Legend Biotech Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Autologous CAR-T Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Autologous CAR-T Cell Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Autologous CAR-T Cell Therapy Market, Segmentation by Type
Target: CD19
Target: BCMA
Other

Global Autologous CAR-T Cell Therapy Market, Segmentation by Application:
Hematological Tumors
Solid Tumor

Companies Profiled:
JW (Cayman) Therapeutics
Gilead (Kite Pharma)
Bristol Myers Squibb
Novartis
Legend Biotech Corporation

Key Questions Answered
1. How big is the global Autologous CAR-T Cell Therapy market?
2. What is the demand of the global Autologous CAR-T Cell Therapy market?
3. What is the year over year growth of the global Autologous CAR-T Cell Therapy market?
4. What is the total value of the global Autologous CAR-T Cell Therapy market?
5. Who are the Major Players in the global Autologous CAR-T Cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Autologous CAR-T Cell Therapy Introduction
    1.2 World Autologous CAR-T Cell Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Autologous CAR-T Cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Autologous CAR-T Cell Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.3 China Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
        1.3.8 India Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Autologous CAR-T Cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.2 World Autologous CAR-T Cell Therapy Consumption Value by Region
        2.2.1 World Autologous CAR-T Cell Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Autologous CAR-T Cell Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.4 China Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.5 Europe Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.6 Japan Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.7 South Korea Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.8 ASEAN Autologous CAR-T Cell Therapy Consumption Value (2019-2030)
    2.9 India Autologous CAR-T Cell Therapy Consumption Value (2019-2030)

3 World Autologous CAR-T Cell Therapy Companies Competitive Analysis
    3.1 World Autologous CAR-T Cell Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Autologous CAR-T Cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Autologous CAR-T Cell Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Autologous CAR-T Cell Therapy in 2023
    3.3 Autologous CAR-T Cell Therapy Company Evaluation Quadrant
    3.4 Autologous CAR-T Cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 Autologous CAR-T Cell Therapy Market: Region Footprint
        3.4.2 Autologous CAR-T Cell Therapy Market: Company Product Type Footprint
        3.4.3 Autologous CAR-T Cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Autologous CAR-T Cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Autologous CAR-T Cell Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Autologous CAR-T Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Autologous CAR-T Cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: Autologous CAR-T Cell Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Autologous CAR-T Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Autologous CAR-T Cell Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Autologous CAR-T Cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Autologous CAR-T Cell Therapy Revenue, (2019-2024)
    4.4 China Based Companies Autologous CAR-T Cell Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Autologous CAR-T Cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Autologous CAR-T Cell Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Autologous CAR-T Cell Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Autologous CAR-T Cell Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Autologous CAR-T Cell Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Autologous CAR-T Cell Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Target: CD19
        5.2.2 Target: BCMA
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Autologous CAR-T Cell Therapy Market Size by Type (2019-2024)
        5.3.2 World Autologous CAR-T Cell Therapy Market Size by Type (2025-2030)
        5.3.3 World Autologous CAR-T Cell Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Autologous CAR-T Cell Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hematological Tumors
        6.2.2 Solid Tumor
    6.3 Market Segment by Application
        6.3.1 World Autologous CAR-T Cell Therapy Market Size by Application (2019-2024)
        6.3.2 World Autologous CAR-T Cell Therapy Market Size by Application (2025-2030)
        6.3.3 World Autologous CAR-T Cell Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 JW (Cayman) Therapeutics
        7.1.1 JW (Cayman) Therapeutics Details
        7.1.2 JW (Cayman) Therapeutics Major Business
        7.1.3 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product and Services
        7.1.4 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 JW (Cayman) Therapeutics Recent Developments/Updates
        7.1.6 JW (Cayman) Therapeutics Competitive Strengths & Weaknesses
    7.2 Gilead (Kite Pharma)
        7.2.1 Gilead (Kite Pharma) Details
        7.2.2 Gilead (Kite Pharma) Major Business
        7.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product and Services
        7.2.4 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Gilead (Kite Pharma) Recent Developments/Updates
        7.2.6 Gilead (Kite Pharma) Competitive Strengths & Weaknesses
    7.3 Bristol Myers Squibb
        7.3.1 Bristol Myers Squibb Details
        7.3.2 Bristol Myers Squibb Major Business
        7.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Product and Services
        7.3.4 Bristol Myers Squibb Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bristol Myers Squibb Recent Developments/Updates
        7.3.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Autologous CAR-T Cell Therapy Product and Services
        7.4.4 Novartis Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Legend Biotech Corporation
        7.5.1 Legend Biotech Corporation Details
        7.5.2 Legend Biotech Corporation Major Business
        7.5.3 Legend Biotech Corporation Autologous CAR-T Cell Therapy Product and Services
        7.5.4 Legend Biotech Corporation Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Legend Biotech Corporation Recent Developments/Updates
        7.5.6 Legend Biotech Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Autologous CAR-T Cell Therapy Industry Chain
    8.2 Autologous CAR-T Cell Therapy Upstream Analysis
    8.3 Autologous CAR-T Cell Therapy Midstream Analysis
    8.4 Autologous CAR-T Cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Autologous CAR-T Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Autologous CAR-T Cell Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Autologous CAR-T Cell Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Autologous CAR-T Cell Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Autologous CAR-T Cell Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Autologous CAR-T Cell Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Autologous CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Autologous CAR-T Cell Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Autologous CAR-T Cell Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Autologous CAR-T Cell Therapy Players in 2023
 Table 12. World Autologous CAR-T Cell Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Autologous CAR-T Cell Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key Autologous CAR-T Cell Therapy Players
 Table 15. Autologous CAR-T Cell Therapy Market: Company Product Type Footprint
 Table 16. Autologous CAR-T Cell Therapy Market: Company Product Application Footprint
 Table 17. Autologous CAR-T Cell Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China Autologous CAR-T Cell Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Autologous CAR-T Cell Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Autologous CAR-T Cell Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Autologous CAR-T Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Autologous CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 23. China Based Autologous CAR-T Cell Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Autologous CAR-T Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Autologous CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Autologous CAR-T Cell Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Autologous CAR-T Cell Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Autologous CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 29. World Autologous CAR-T Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Autologous CAR-T Cell Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Autologous CAR-T Cell Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Autologous CAR-T Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Autologous CAR-T Cell Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Autologous CAR-T Cell Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. JW (Cayman) Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 36. JW (Cayman) Therapeutics Major Business
 Table 37. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product and Services
 Table 38. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. JW (Cayman) Therapeutics Recent Developments/Updates
 Table 40. JW (Cayman) Therapeutics Competitive Strengths & Weaknesses
 Table 41. Gilead (Kite Pharma) Basic Information, Manufacturing Base and Competitors
 Table 42. Gilead (Kite Pharma) Major Business
 Table 43. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product and Services
 Table 44. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Gilead (Kite Pharma) Recent Developments/Updates
 Table 46. Gilead (Kite Pharma) Competitive Strengths & Weaknesses
 Table 47. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 48. Bristol Myers Squibb Major Business
 Table 49. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product and Services
 Table 50. Bristol Myers Squibb Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Bristol Myers Squibb Recent Developments/Updates
 Table 52. Bristol Myers Squibb Competitive Strengths & Weaknesses
 Table 53. Novartis Basic Information, Manufacturing Base and Competitors
 Table 54. Novartis Major Business
 Table 55. Novartis Autologous CAR-T Cell Therapy Product and Services
 Table 56. Novartis Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Novartis Recent Developments/Updates
 Table 58. Novartis Competitive Strengths & Weaknesses
 Table 59. Legend Biotech Corporation Basic Information, Manufacturing Base and Competitors
 Table 60. Legend Biotech Corporation Major Business
 Table 61. Legend Biotech Corporation Autologous CAR-T Cell Therapy Product and Services
 Table 62. Legend Biotech Corporation Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Legend Biotech Corporation Recent Developments/Updates
 Table 64. Legend Biotech Corporation Competitive Strengths & Weaknesses
 Table 65. Global Key Players of Autologous CAR-T Cell Therapy Upstream (Raw Materials)
 Table 66. Global Autologous CAR-T Cell Therapy Typical Customers


List of Figures
 Figure 1. Autologous CAR-T Cell Therapy Picture
 Figure 2. World Autologous CAR-T Cell Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Autologous CAR-T Cell Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Autologous CAR-T Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Autologous CAR-T Cell Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Autologous CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. Autologous CAR-T Cell Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Autologous CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Autologous CAR-T Cell Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Autologous CAR-T Cell Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Autologous CAR-T Cell Therapy Markets in 2023
 Figure 27. United States VS China: Autologous CAR-T Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Autologous CAR-T Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Autologous CAR-T Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Autologous CAR-T Cell Therapy Market Size Market Share by Type in 2023
 Figure 31. Target: CD19
 Figure 32. Target: BCMA
 Figure 33. Other
 Figure 34. World Autologous CAR-T Cell Therapy Market Size Market Share by Type (2019-2030)
 Figure 35. World Autologous CAR-T Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Autologous CAR-T Cell Therapy Market Size Market Share by Application in 2023
 Figure 37. Hematological Tumors
 Figure 38. Solid Tumor
 Figure 39. World Autologous CAR-T Cell Therapy Market Size Market Share by Application (2019-2030)
 Figure 40. Autologous CAR-T Cell Therapy Industrial Chain
 Figure 41. Methodology
 Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

JW (Cayman) Therapeutics
Gilead (Kite Pharma)
Bristol Myers Squibb
Novartis
Legend Biotech Corporation

Related Reports

Global Autologous CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Autologous CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 06 Sep 2024

date Medical Care

Product Tags

Autologous CAR-T Cell Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>